301 related articles for article (PubMed ID: 8598041)
1. H2-M mutant mice are defective in the peptide loading of class II molecules, antigen presentation, and T cell repertoire selection.
Martin WD; Hicks GG; Mendiratta SK; Leva HI; Ruley HE; Van Kaer L
Cell; 1996 Feb; 84(4):543-50. PubMed ID: 8598041
[TBL] [Abstract][Full Text] [Related]
2. Mice lacking H2-M complexes, enigmatic elements of the MHC class II peptide-loading pathway.
Miyazaki T; Wolf P; Tourne S; Waltzinger C; Dierich A; Barois N; Ploegh H; Benoist C; Mathis D
Cell; 1996 Feb; 84(4):531-41. PubMed ID: 8598040
[TBL] [Abstract][Full Text] [Related]
3. Relaxed DM requirements during class II peptide loading and CD4+ T cell maturation in BALB/c mice.
Bikoff EK; Wutz G; Kenty GA; Koonce CH; Robertson EJ
J Immunol; 2001 Apr; 166(8):5087-98. PubMed ID: 11290790
[TBL] [Abstract][Full Text] [Related]
4. Distinct peptide loading pathways for MHC class II molecules associated with alternative Ii chain isoforms.
Bikoff EK; Kenty G; Van Kaer L
J Immunol; 1998 Apr; 160(7):3101-10. PubMed ID: 9531264
[TBL] [Abstract][Full Text] [Related]
5. Altered major histocompatibility complex class II peptide loading in H2-O-deficient mice.
Perraudeau M; Taylor PR; Stauss HJ; Lindstedt R; Bygrave AE; Pappin DJ; Ellmerich S; Whitten A; Rahman D; Canas B; Walport MJ; Botto M; Altmann DM
Eur J Immunol; 2000 Oct; 30(10):2871-80. PubMed ID: 11069069
[TBL] [Abstract][Full Text] [Related]
6. Effect of decreasing the affinity of the class II-associated invariant chain peptide on the MHC class II peptide repertoire in the presence or absence of H-2M.
Honey K; Forbush K; Jensen PE; Rudensky AY
J Immunol; 2004 Apr; 172(7):4142-50. PubMed ID: 15034026
[TBL] [Abstract][Full Text] [Related]
7. Antigen presentation and T cell development in H2-M-deficient mice.
Fung-Leung WP; Surh CD; Liljedahl M; Pang J; Leturcq D; Peterson PA; Webb SR; Karlsson L
Science; 1996 Mar; 271(5253):1278-81. PubMed ID: 8638109
[TBL] [Abstract][Full Text] [Related]
8. Expression and function of transgenic HLA-DQ molecules and lymphocyte development in mice lacking invariant chain.
Rajagopalan G; Smart MK; Krco CJ; David CS
J Immunol; 2002 Aug; 169(4):1774-83. PubMed ID: 12165499
[TBL] [Abstract][Full Text] [Related]
9. Cathepsin L regulates CD4+ T cell selection independently of its effect on invariant chain: a role in the generation of positively selecting peptide ligands.
Honey K; Nakagawa T; Peters C; Rudensky A
J Exp Med; 2002 May; 195(10):1349-58. PubMed ID: 12021314
[TBL] [Abstract][Full Text] [Related]
10. Downmodulation of antigen presentation by H2-O in B cell lines and primary B lymphocytes.
Brocke P; Armandola E; Garbi N; Hämmerling GJ
Eur J Immunol; 2003 Feb; 33(2):411-21. PubMed ID: 12645938
[TBL] [Abstract][Full Text] [Related]
11. MHC class II loading of high or low affinity peptides directed by Ii/peptide fusion constructs: implications for T cell activation.
Gregers TF; Fleckenstein B; Vartdal F; Roepstorff P; Bakke O; Sandlie I
Int Immunol; 2003 Nov; 15(11):1291-9. PubMed ID: 14565927
[TBL] [Abstract][Full Text] [Related]
12. Unexpected reactivities of T cells selected by a single MHC-peptide ligand.
Singh N; Van Kaer L
J Immunol; 1999 Oct; 163(7):3583-91. PubMed ID: 10490950
[TBL] [Abstract][Full Text] [Related]
13. Invariant chains with the class II binding site replaced by a sequence from influenza virus matrix protein constrain low-affinity sequences to MHC II presentation.
Carstens C; Newman DK; Bohlen H; König A; Koch N
Int Immunol; 2000 Nov; 12(11):1561-8. PubMed ID: 11058576
[TBL] [Abstract][Full Text] [Related]
14. Asparagine endopeptidase is not essential for class II MHC antigen presentation but is required for processing of cathepsin L in mice.
Maehr R; Hang HC; Mintern JD; Kim YM; Cuvillier A; Nishimura M; Yamada K; Shirahama-Noda K; Hara-Nishimura I; Ploegh HL
J Immunol; 2005 Jun; 174(11):7066-74. PubMed ID: 15905550
[TBL] [Abstract][Full Text] [Related]
15. Invariant chain-independent function of H-2M in the formation of endogenous peptide-major histocompatibility complex class II complexes in vivo.
Kovats S; Grubin CE; Eastman S; deRoos P; Dongre A; Van Kaer L; Rudensky AY
J Exp Med; 1998 Jan; 187(2):245-51. PubMed ID: 9432982
[TBL] [Abstract][Full Text] [Related]
16. Defective major histocompatibility complex class II assembly, transport, peptide acquisition, and CD4+ T cell selection in mice lacking invariant chain expression.
Bikoff EK; Huang LY; Episkopou V; van Meerwijk J; Germain RN; Robertson EJ
J Exp Med; 1993 Jun; 177(6):1699-712. PubMed ID: 8098731
[TBL] [Abstract][Full Text] [Related]
17. Impaired antigen presentation by murine I-Ad class II MHC molecules expressed in normal and HLA-DM-defective human B cell lines.
Weenink S; Averdunk H; Boston T; Boswarva V; Guery JC; Adorini L; Mellins E; McCluskey J; Gautam AM
Int Immunol; 1997 Jun; 9(6):889-96. PubMed ID: 9199972
[TBL] [Abstract][Full Text] [Related]
18. Expression and function of HLA-DR3 and DQ8 in transgenic mice lacking functional H2-M.
Rajagopalan G; Smart MK; Cheng S; Krco CJ; Johnson KL; David CS
Tissue Antigens; 2003 Aug; 62(2):149-61. PubMed ID: 12889995
[TBL] [Abstract][Full Text] [Related]
19. Major histocompatibility complex class II+ invariant chain negative breast cancer cells present unique peptides that activate tumor-specific T cells from breast cancer patients.
Chornoguz O; Gapeev A; O'Neill MC; Ostrand-Rosenberg S
Mol Cell Proteomics; 2012 Nov; 11(11):1457-67. PubMed ID: 22942358
[TBL] [Abstract][Full Text] [Related]
20. T cell recognition of major histocompatibility complex class II complexes with invariant chain processing intermediates.
Morkowski S; Goldrath AW; Eastman S; Ramachandra L; Freed DC; Whiteley P; Rudensky AYu
J Exp Med; 1995 Nov; 182(5):1403-13. PubMed ID: 7595211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
